Know Cancer

or
forgot password

Bio-Behavioral Lung Cancer Prevention Program


Phase 4
18 Years
N/A
Not Enrolling
Both
Smoking Cessation

Thank you

Trial Information

Bio-Behavioral Lung Cancer Prevention Program


Inclusion Criteria:



Eligible smokers will be those currently smoking at least 10 cigarettes a day.

Exclusion Criteria:

Exclusionary criteria are: planning a pregnancy, pregnancy, lactating, seizure disorder,
history of head trauma or prior seizure, family history of a seizure disorder, brain (or
CNS) tumor, history of or currently diagnosed with bulimia or anorexia nervosa, diabetes
treated with oral hypoglycemics or insulin, excessive use of alcohol or alcoholism,
current addiction to opiates, cocaine, or stimulants, use of other drugs containing
bupropion (e.g., Wellbutrin, Wellbutrin SR), allergy to bupropion, currently taking
particular medications (e.g., monoamine oxidase inhibitor, antipsychotics,
antidepressants, theophylline, systemic steroids, over-the-counter stimulants and
anorectics), recently taken a MAOI (less than 14 days) or a recent discontinuation of a
benzodiazepine.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Outcome Measure:

Continuous abstinence: measured at end of treatment and at 6- and 12- months after cessation.

Principal Investigator

Caryn Lerman

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Pennsylvania

Authority:

United States: Federal Government

Study ID:

703463

NCT ID:

NCT00322205

Start Date:

June 1999

Completion Date:

March 2002

Related Keywords:

  • Smoking Cessation
  • Lung Neoplasms
  • Smoking

Name

Location

State University of New YorkBuffalo, New York  14203-1154